JavaScript is disabled. Please enable to continue!

Mobile search icon
Formazione >> Webinar e Formazione Online >> Free Webinar "Treated articles: Regulatory scenario and efficacy assessment"

Free Webinar "Treated articles: Regulatory scenario and efficacy assessment"

Sidebar Image

Date: October 28th, 2020 (2.30 PM - 04.00 PM)

Free Online Webinar 

Attendees capacity: 60 delegates

> Interested to attend another session of this webinar? Contact us

The webinar will be hosted through Go ToWebinar platform. Delegates will receive access details prior the event.

Introduction

Treated articles are substances, mixtures or articles that have been treated with a biocide or into which a biocide has been intentionally incorporated (impregnated wood, paint that is formulated with a preservative, anti-odour socks, antibacterial carpet, etc.). Treated articles whose primary function is biocidal are classified as biocidal products.

The Biocidal Products Regulation (BPR) contains provisions under Article 58 on treated articles and apply to articles and mixtures that have been treated with or incorporate a biocidal product. Articles are defined under the REACH Regulation (EC) No 1907/2006. In particular, articles can only be treated with active substances that have been approved in the EU for that purpose. This is a significant change to the previous scheme, where articles imported from non-EU countries were permitted to have been treated with substances that are not allowed in the EU.

An important aspect is that treated articles must be appropriately labelled. If the manufacturer of the treated article includes a claim related to the biocidal properties of the article or if instructions are included related to hazards for humans or the environment, then appropriate labelling is obligatory. Finally, anyone supplying treated articles on the market must provide, free of charge when requested, information on the biocidal treatment of the treated article. 

In the current scenario treated articles have gained major relevance, due to the presence of microorganisms (bacteria, fungi and viruses) in or on various items, that have become of increased concern to consumers. In response to these concerns, many products are being treated with antimicrobial substances used to destroy or limit the growth of microorganisms, whether bacteria, viruses, or fungi on inanimate objects and surfaces - reason why scientific evidence must be available and chemical data must be submitted in support of the public health labeling claims and patterns of use of the product.

Distinction between treated articles, biocidal products and articles out of scope is important but complex. Only active substances approved for the right PT and use are permitted. This webinar aims to provide useful information on regulatory aspects affecting treated articles as well as specific labelling provisions to protect human health, animal health and the environment. It will also provide sound experience on how the efficacy of treated articles can be assessed using laboratory based protocols by using the latest methods. It includes a structure for possible claims for treated articles and treated materials, as well as information on different types of claims and how to support them by providing data that is relevant to the actual use and guarantee that public health is protected.

Agenda

Overview on treated articles
Regulatory scenario: Biocidal Products Regulation (BPR) Article 58 and REACH Regulation (EC) No 1907/2006
Daniela Romano, PhD - Eurofins Biolab

What are the obligations for treated articles?   
Labelling and information on treated articles: Treated article with biocidal properties, active substance used to treat the article was approved subject to specific labelling provisions
When does a claim not trigger BPR requirements?
Consumer information on request 
Dr.ssa Elena Conti - CATAS

Efficacy assessment for preservatives products, porous and non-porous material and surfaces
Dr. Michele Cavalleri - Eurofins Biolab

Keynote Speakers

Daniela Romano - Eurofins Biolab
After her PhD in Biophysics and a Post Doc position in medical research, Daniela has been working with Eurofins, mainly on Biocides, since 2003. She was first in charge of stability studies and then the management of the Chemistry laboratory. She managed projects aiming towards Biocidal Products authorisation for several years and is now also involved in the risk assessment procedures. She has sound experience with a large variety of biocidal products.

Elena Conti - CATAS
Elena Conti Graduated in Biological Sciences has developed working experience in the field of applied biotechnology. Since 2002 is Responsible of the biological testing laboratory at CATAS (Italy), with main focus on the application and development of methods for the assessment of the resistance of materials to microbial attack and efficacy of protective treatments against biodeterioration. She is involved in standardization activities both at national and European level as coordinator of working groups.

Michele Cavalleri - Eurofins Biolab
GLP Facility Manager of the Biocidal Products Division in Eurofins Biolab (Italy). He has gained a solid expertise on efficay assessment of disinfectants. He is also member of the European Committee CEN TC 216 that establishes standardized methods of test and requirements for the antimicrobial efficacy of chemical disinfectants and antiseptics.